Literature DB >> 24976097

Mechanical thrombectomy versus intrasinus thrombolysis for cerebral venous sinus thrombosis: a non-randomized comparison.

Fazeel M Siddiqui1, Chirantan Banerjee2, Susanna M Zuurbier3, Qing Hao4, Chul Ahn2, Glenn L Pride2, Muhammad Wasay5, Charles Blm Majoie3, David Liebeskind4, Mark Johnson2, Jan Stam3.   

Abstract

Small retrospective studies have shown the benefit of endovascular treatment with intrasinus thrombolysis (IST) or mechanical thrombectomy (MT) with/without IST (MT ± IST) in cases of multifocal cerebral venous thrombosis (CVT). Our study compares the mortality, functional outcome and periprocedural complications among patients treated with MT ± IST versus IST alone. We reviewed clinical and angiographic findings of 63 patients with CVT who received endovascular treatment at three tertiary care centers. Primary outcome variables were discharge mortality and neurological dysfunction, and intermediate (three months) and long-term (>six months) morbidity. The modified Rankin scale (mRS) was used to assess morbidity. mRS ≤ 1 was considered a good recovery. Neurological dysfunction was rated as neuroscore: 0, normal; 1, mild (ambulatory, communicative); 2, moderate (non-ambulatory, communicative); and 3, severe (non-ambulatory, non-communicative/comatose). In patients who received IST alone, presenting neurological deficits were comparatively minor (p<0.001). When the two groups were adjusted for admission neuroscore, there was no statistical significance between discharge mortality [7(21%) versus 4(14%), p=0.228], neurological dysfunction (p=0.442), intermediate (p=0.336) and long-term morbidity (p=0.988). Patients who received MT ± IST had a higher percentage of periprocedural complications without reaching statistical significance. Compared to IST, MT was performed in severe cases with extensive sinus involvement. When adjusted for admission neurological dysfunction, both groups had similar mortality and discharge neurological dysfunction and similar intermediate and long-term morbidity.

Entities:  

Keywords:  cerebral venous thrombosis; stroke; thrombectomy; thrombolysis

Mesh:

Substances:

Year:  2014        PMID: 24976097      PMCID: PMC4178772          DOI: 10.15274/INR-2014-10032

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  36 in total

1.  Treatment of dural sinus thrombosis with local urokinase infusion. Case report.

Authors:  J A Scott; R M Pascuzzi; P V Hall; G J Becker
Journal:  J Neurosurg       Date:  1988-02       Impact factor: 5.115

2.  Extensive dural sinus thrombosis: successful recanalization with thrombolysis and a novel thrombectomy device.

Authors:  Kristine A Blackham
Journal:  J Neurosurg       Date:  2010-03-05       Impact factor: 5.115

3.  Heparin treatment in sinus venous thrombosis.

Authors:  K M Einhäupl; A Villringer; W Meister; S Mehraein; C Garner; M Pellkofer; R L Haberl; H W Pfister; P Schmiedek
Journal:  Lancet       Date:  1991-09-07       Impact factor: 79.321

4.  Mechanical thrombectomy with the penumbra system for treatment of venous sinus thrombosis.

Authors:  Armen Choulakian; Michael J Alexander
Journal:  J Neurointerv Surg       Date:  2010-03-05       Impact factor: 5.836

5.  Cerebral venous congestion as indication for thrombolytic treatment.

Authors:  Fong Y Tsai; Varoujan Kostanian; Monica Rivera; Kwo-Whie Lee; Clayton C Chen; Thong H Nguyen
Journal:  Cardiovasc Intervent Radiol       Date:  2007 Jul-Aug       Impact factor: 2.740

Review 6.  Thrombolytics for cerebral sinus thrombosis: a systematic review.

Authors:  Patricia Canhão; Filipa Falcão; José M Ferro
Journal:  Cerebrovasc Dis       Date:  2003       Impact factor: 2.762

7.  Continuous thrombolysis and repeated thrombectomy with the Penumbra System in a child with hemorrhagic sinus thrombosis: technical note.

Authors:  Zsolt Kulcsár; Miklós Marosfoi; Zsolt Berentei; István Szikora
Journal:  Acta Neurochir (Wien)       Date:  2009-12-17       Impact factor: 2.216

8.  Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).

Authors:  José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2004-02-19       Impact factor: 7.914

9.  Rheolytic thrombectomy for dural venous sinus thrombosis.

Authors:  Kalgi Modi; Vijay Misra; Pratap Reddy
Journal:  J Neuroimaging       Date:  2008-10-21       Impact factor: 2.486

10.  Delay in diagnosis of cerebral venous and sinus thrombosis: successful use of mechanical thrombectomy and thrombolysis.

Authors:  Christopher T Shah; Jason J Rizqallah; Oladoyin Oluwole; Aleksandrs Kalnins; John N Sheagren
Journal:  Case Rep Med       Date:  2011-07-09
View more
  22 in total

Review 1.  Deep Cerebral Venous Thrombosis Treatment : Endovascular Case using Aspiration and Review of the Various Treatment Modalities.

Authors:  Leonard Ll Yeo; Priscillia Ps Lye; Kong Wan Yee; Yang Cunli; Tu Tian Ming; Andrew Fw Ho; Vijay K Sharma; Bernard Pl Chan; Benjamin Yq Tan; Anil Gopinathan
Journal:  Clin Neuroradiol       Date:  2020-06-11       Impact factor: 3.649

2.  Combined aspiration thrombectomy and continuous intrasinus thrombolysis for cerebral venous sinus thrombosis: technical note and case series.

Authors:  Anderson Chun On Tsang; A C Hwang; R H Y Chiu; D Y C Chan; F C P Tsang; W S Ho; R Lee; G K K Leung; W M Lui
Journal:  Neuroradiology       Date:  2018-08-21       Impact factor: 2.804

3.  Cerebral Venous Sinus Thrombosis : Endovascular Treatment with Rheolysis and Aspiration thrombectomy.

Authors:  P Bhogal; M AlMatter; M Aguilar; I Nakagawa; O Ganslandt; H Bäzner; H Henkes
Journal:  Clin Neuroradiol       Date:  2016-09-12       Impact factor: 3.649

Review 4.  Stroke in Pregnancy: A Focused Update.

Authors:  Eliza C Miller; Lisa Leffert
Journal:  Anesth Analg       Date:  2020-04       Impact factor: 5.108

5.  [Diagnostic and treatment standards for cerebral sinus venous thrombosis : Results of an online survey of German stroke units].

Authors:  C Geisbüsch; P A Ringleb; O Busse; G F Hamann; S Nagel
Journal:  Nervenarzt       Date:  2017-10       Impact factor: 1.214

Review 6.  Endovascular treatments for cerebral venous sinus thrombosis.

Authors:  Zhongming Qiu; Hongfei Sang; Qiliang Dai; Gelin Xu
Journal:  J Thromb Thrombolysis       Date:  2015-10       Impact factor: 2.300

Review 7.  Cerebral venous thrombosis: state of the art diagnosis and management.

Authors:  Adam A Dmytriw; Jin Soo A Song; Eugene Yu; Colin S Poon
Journal:  Neuroradiology       Date:  2018-05-11       Impact factor: 2.804

8.  Prolonged Microcatheter-Based Local Thrombolytic Infusion as a Salvage Treatment After Failed Endovascular Treatment for Cerebral Venous Thrombosis: A Multicenter Experience.

Authors:  Adnan I Qureshi; Mikayel Grigoryan; Muhammad A Saleem; Emrah Aytac; Shawn S Wallery; Gustavo J Rodriguez; Muhammad F K Suri
Journal:  Neurocrit Care       Date:  2018-08       Impact factor: 3.210

9.  Endovascular treatment for hemorrhagic cerebral venous sinus thrombosis: experience with 9 cases for 3 years.

Authors:  Shizhong Zhang; Yanyan Hu; Zhen Li; Dezhang Huang; Mingran Zhang; Chenglong Wang; Zhigang Wang
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

Review 10.  Maternal Stroke: A Call for Action.

Authors:  Islam Y Elgendy; Syed Bukhari; Amr F Barakat; Carl J Pepine; Kathryn J Lindley; Eliza C Miller
Journal:  Circulation       Date:  2021-02-15       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.